Literature DB >> 29666072

Left Ventricular Assist Device Inflow Cannula Angle and Thrombosis Risk.

Venkat Keshav Chivukula1, Jennifer A Beckman1, Anthony R Prisco1, Todd Dardas1, Shin Lin1, Jason W Smith1, Nahush A Mokadam1, Alberto Aliseda1, Claudius Mahr2.   

Abstract

BACKGROUND: As heart failure prevalence continues to increase in the setting of a static donor supply, left ventricular assist device (LVAD) therapy for end-stage heart failure continues to grow. Anecdotal evidence suggests that malalignment of the LVAD inflow cannula may increase thrombosis risk, but this effect has not been explored mechanistically or quantified statistically. Our objective is to elucidate the impact of surgical angulation of the inflow cannula on thrombogenicity. METHODS AND
RESULTS: Unsteady computational fluid dynamics is used in conjunction with computational modeling and virtual surgery to model flow through the left ventricle for 5 different inflow cannula angulations. We use a holistic approach to evaluate thrombogenicity: platelet-based (Lagrangian) metrics to evaluate the platelet mechanical environment, combined with flow-based (Eulerian) metrics to investigate intraventricular hemodynamics. The thrombogenic potential of each LVAD inflow cannula angulation is quantitatively evaluated based on platelet shear stress history and residence time. Intraventricular hemodynamics are strongly influenced by LVAD inflow cannula angulation. Platelet behavior indicates elevated thrombogenic potential for certain inflow cannula angles, potentially leading to platelet activation. Our analysis demonstrates that the optimal range of inflow angulation is within 0±7° of the left ventricular apical axis.
CONCLUSIONS: Angulation of the inflow cannula >7° from the apical axis (axis connecting mitral valve and ventricular apex) leads to markedly unfavorable hemodynamics as determined by computational fluid dynamics. Computational hemodynamic simulations incorporating Lagrangian and Eulerian metrics are a powerful tool for studying optimization of LVAD implantation strategies, with the long-term potential of improving outcomes.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  cannula; heart assist devices; heart ventricles; stroke; thrombosis

Mesh:

Year:  2018        PMID: 29666072     DOI: 10.1161/CIRCHEARTFAILURE.117.004325

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  17 in total

1.  Prothrombotic activity of cytokine-activated endothelial cells and shear-activated platelets in the setting of ventricular assist device support.

Authors:  Alice Apostoli; Valentina Bianchi; Nina Bono; Annalisa Dimasi; Kaitlyn R Ammann; Yana Roka Moiia; Andrea Montisci; Jawaad Sheriff; Danny Bluestein; Gianfranco B Fiore; Federico Pappalardo; Gabriele Candiani; Alberto Redaelli; Marvin J Slepian; Filippo Consolo
Journal:  J Heart Lung Transplant       Date:  2019-02-18       Impact factor: 10.247

2.  Mathematical and Computational Modeling of Device-Induced Thrombosis.

Authors:  Keefe B Manning; Franck Nicoud; Susan M Shea
Journal:  Curr Opin Biomed Eng       Date:  2021-09-28

3.  A New Mathematical Numerical Model to Evaluate the Risk of Thrombosis in Three Clinical Ventricular Assist Devices.

Authors:  Yuan Li; Hongyu Wang; Yifeng Xi; Anqiang Sun; Xiaoyan Deng; Zengsheng Chen; Yubo Fan
Journal:  Bioengineering (Basel)       Date:  2022-05-27

4.  Numerical study of the effect of LVAD inflow cannula positioning on thrombosis risk.

Authors:  Ge He; Lu Han; Jiafeng Zhang; Aakash Shah; David J Kaczorowski; Bartley P Griffith; Zhongjun Wu
Journal:  Comput Methods Biomech Biomed Engin       Date:  2021-10-01       Impact factor: 1.669

5.  Understanding the influence of left ventricular assist device inflow cannula alignment and the risk of intraventricular thrombosis.

Authors:  Michael Neidlin; Sam Liao; Zhiyong Li; Benjamin Simpson; David M Kaye; Ulrich Steinseifer; Shaun Gregory
Journal:  Biomed Eng Online       Date:  2021-05-11       Impact factor: 2.819

6.  In vitro real-time magnetic resonance imaging for quantification of thrombosis.

Authors:  Ling Yang; Thomas Neuberger; Keefe B Manning
Journal:  MAGMA       Date:  2020-07-29       Impact factor: 2.310

7.  Evolving perspectives on mechanical circulatory support biocompatibility and interfaces.

Authors:  Marvin J Slepian; Joseph Italiano; Danny Bluestein; Jawaad Sheriff; Yana Roka-Moiia
Journal:  Ann Cardiothorac Surg       Date:  2021-05

8.  Patient-Specific Computational Fluid Dynamics Reveal Localized Flow Patterns Predictive of Post-Left Ventricular Assist Device Aortic Incompetence.

Authors:  Rohan Shad; Alexander D Kaiser; Sandra Kong; Robyn Fong; Nicolas Quach; Cayley Bowles; Patpilai Kasinpila; Yasuhiro Shudo; Jeffrey Teuteberg; Y Joseph Woo; Alison L Marsden; William Hiesinger
Journal:  Circ Heart Fail       Date:  2021-06-18       Impact factor: 10.447

9.  Impact of the HeartMate 3 continuous-flow left ventricular assist device in patients with small body size.

Authors:  Kohei Tonai; Satsuki Fukushima; Naoki Tadokoro; Satoshi Kainuma; Naonori Kawamoto; Takashi Kakuta; Ayumi Koga-Ikuta; Takuya Watanabe; Osamu Seguchi; Yasumasa Tsukamoto; Norihide Fukushima; Tomoyuki Fujita
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

10.  Continuous LVAD monitoring reveals high suction rates in clinically stable outpatients.

Authors:  Christoph Gross; Heinrich Schima; Thomas Schlöglhofer; Kamen Dimitrov; Martin Maw; Julia Riebandt; Dominik Wiedemann; Daniel Zimpfer; Francesco Moscato
Journal:  Artif Organs       Date:  2020-03-01       Impact factor: 3.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.